LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 42.81 | 27.76 | 2984 | 3596 | 0.8297 | 0.9475 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 42.81 | 27.76 | 3018 | 3596 | 0.8392 | 0.9507 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 42.81 | 27.76 | 1165 | 3596 | 0.3240 | 0.7032 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 42.81 | 27.76 | 3542 | 3596 | 0.9849 | 0.9957 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 44.52 | 27.76 | 3195 | 3884 | 0.8226 | 0.9459 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 44.52 | 27.76 | 3219 | 3884 | 0.8287 | 0.9480 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 44.52 | 27.76 | 1335 | 3884 | 0.3437 | 0.7217 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 44.52 | 27.76 | 3733 | 3884 | 0.9611 | 0.9889 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.22 | 27.76 | 3403 | 4125 | 0.8250 | 0.9474 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.22 | 27.76 | 3431 | 4125 | 0.8318 | 0.9496 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.22 | 27.76 | 1416 | 4125 | 0.3433 | 0.7245 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 46.22 | 27.76 | 3925 | 4125 | 0.9515 | 0.9863 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 47.93 | 27.76 | 3603 | 4421 | 0.8149 | 0.9448 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 47.93 | 27.76 | 3631 | 4421 | 0.8212 | 0.9469 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 47.93 | 27.76 | 1647 | 4421 | 0.3725 | 0.7475 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 47.93 | 27.76 | 4174 | 4421 | 0.9440 | 0.9843 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 49.63 | 27.76 | 3820 | 4818 | 0.7929 | 0.9386 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 49.63 | 27.76 | 3845 | 4818 | 0.7980 | 0.9403 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 49.63 | 27.76 | 1862 | 4818 | 0.3865 | 0.7601 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 49.63 | 27.76 | 4355 | 4818 | 0.9039 | 0.9730 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 51.33 | 27.76 | 4021 | 5117 | 0.7858 | 0.9370 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 51.33 | 27.76 | 4043 | 5117 | 0.7901 | 0.9384 | MN20160318_Q01 | H11 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 51.33 | 27.76 | 1950 | 5117 | 0.3811 | 0.7594 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 51.33 | 27.76 | 4649 | 5117 | 0.9085 | 0.9747 | MN20160318_Q01 | M13 |
MCF 10A-H2B-mCherry | Trametinib | 0.001 | 53.04 | 27.76 | 4240 | 5365 | 0.7902 | 0.9389 | MN20160318_Q01 | H11 |